Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 57,180 shares at $12.49 ($751K) on 2026-03-27, disclosed to the SEC on 2026-03-31.
Scheduled sale ($751k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.49 | 2,738 | $34K | 4.6% |
| 2 | $13.48 | 16,322 | $220K | 29.3% |
| 3 | $12.63 | 19,060 | $241K | 32.0% |
| 4 | $13.45 | 19,060 | $256K | 34.1% |
| Total | $13.14 avg | 57,180 | $751K | 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |